Physician profile
Daniel Bazylewicz
NPI 1538393178
$3,095.78
in general payments reported to CMS, 2019-2025
9 companies · $1,070 in 2025
The $1,070 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2021: $47.55 · 2023: $44.26 · 2024: $1,584 · 2025: $1,070.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,379 · Travel and Lodging: $1,319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,378.70 |
| Travel and Lodging | $1,319.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,672.34 | 2019-2024 | Everest Spinal System, Gamma |
| Vb Spine LLC | $510.42 | 2025 | Everest Spinal System |
| Medtronic, INC. | $312.91 | 2025 | Prestige LP Cervical Disc System |
| Alphatec Spine, INC | $155.95 | 2025 | Invictus Open, Identiti |
| Si-Bone, INC. | $149.32 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $120.92 | 2019 | |
| Depuy Synthes Sales INC. | $90.85 | 2019 | |
| Medical Device Business Services, INC. | $67.90 | 2019 | |
| Eclipse Technology Solutions INC. | $15.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Bazylewicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.